Kidney and Urinary Tract Involvement in Chronic Myelomonocytic Leukemia.
Chronic myelomonocytic leukemia
glomerulopathy
kidney injury
lysozyme-induced nephropathy
onconephrology
tumor lysis syndrome
vasculitis
Journal
Kidney medicine
ISSN: 2590-0595
Titre abrégé: Kidney Med
Pays: United States
ID NLM: 101756300
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
medline:
5
2
2024
pubmed:
5
2
2024
entrez:
5
2
2024
Statut:
epublish
Résumé
Chronic myelomonocytic leukemia (CMML) is a hematologic malignancy affecting the bone marrow and resulting in peripheral blood monocytosis. Kidney and urinary tract involvement is common and can present dramatically with life-threatening consequences. Kidney involvement can be the result of direct or indirect mechanisms, including prerenal azotemia, glomerular disease, tubulointerstitial involvement, and renovascular disorders. Urinary tract involvement, electrolyte and acid-base disorders, as well as nephrotoxicity from treatment of the disorder can also occur. Given this multifactorial pathogenesis involving several mechanisms concomitantly, nephrologists must exercise heightened awareness and maintain a low threshold for kidney biopsy. There is a pressing need for future research endeavors to elucidate and target the manifestations of CMML that involve the kidneys with the ultimate goal of augmenting overall prognosis and therapeutic outcomes.
Identifiants
pubmed: 38313809
doi: 10.1016/j.xkme.2023.100769
pii: S2590-0595(23)00187-5
pmc: PMC10837097
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100769Informations de copyright
© 2023 The Authors.